3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-cyclopenten-1-one → N-[6-(3-oxocyclopenten-1-yl)pyridazin-3-yl]-2-pyridin-2-ylacetamide
Reaction equation
Br[c:1]1[n:16][n:15][c:4]([NH:5][C:6]([CH2:8][c:9]2[n:14][cH:13][cH:12][cH:11][cH:10]2)=[O:7])[cH:3][cH:2]1.CC1(C(C)(C)OB([C:17]([CH2:22][CH2:21][C:19]2=[O:20])=[CH:18]2)O1)C>>[O:7]=[C:6]([NH:5][c:4]1[n:15][n:16][c:1]([C:17]([CH2:22][CH2:21][C:19]2=[O:20])=[CH:18]2)[cH:2][cH:3]1)[CH2:8][c:9]3[n:14][cH:13][cH:12][cH:11][cH:10]3Participants
9
Reactant 2
Product 1
Reagents, catalysts & solvents 6
Conditions
- Temperature
- 80 °C
Sources & evidence
- ORD record
- ord-82a7f0a668404e6b8ba2a4728aa73c3c
- Source dataset
- 39k HTE dataset from Pfizer
- Original link
- View source
Reaction notes
Loading…